Glucose-derived spiro-isoxazolines are anti-hyperglycemic agents against type 2 diabetes through glycogen phosphorylase inhibition

Autor: Goyard, David, Kónya, Bálint, Chajistamatiou, Aikaterini S., Chrysina, Evangelia D., Leroy, Jérémy, Balzarin, Sophie, Tournier, Michel, Tousch, Didier, Petit, Pierre, Duret, Cédric, Maurel, Patrick, Somsák, László, Docsa, Tibor, Gergely, Pál, Praly, Jean-Pierre, Azay-Milhau, Jacqueline, Vidal, Sébastien
Zdroj: In European Journal of Medicinal Chemistry 27 January 2016 108:444-454
Databáze: ScienceDirect
Externí odkaz: